UK Invests £9.9m to turn recycled nuclear material into lead-212 cancer therapies
A new UK-wide programme will use recycled nuclear fuel to create sustainable lead-212 targeted alpha therapies, aiming to deliver next-generation precision cancer treatments for hard-to-treat tumours